Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Registry studies of long-term multiple sclerosis outcomes: description of key registries.

Neurology·2011
Same author

The diagnosis of multiple sclerosis and the clinical subtypes.

Annals of Indian Academy of Neurology·2010
Same author

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.

Clinical therapeutics·2008
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Analysis of current multiple sclerosis registries.

Barrie J Hurwitz1

  • 1Department of Medicine Neurology, Box 3184, Duke University Medical Center, Durham, NC 27710, USA. hurwi003@mc.duke.edu

Neurology
|January 6, 2011
PubMed
Summary

Multiple sclerosis (MS) patient registries show consistent data on disability progression and reduced lifespan. These findings highlight MS as a public health concern, necessitating integrated treatment strategies.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: Jun 5, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

  • Neurology
  • Public Health
  • Clinical Research

Background:

  • Patient registries offer unique data crucial for understanding disease patterns.
  • Cross-registry validation enhances the reliability of observed findings.
  • Multiple Sclerosis (MS) registry studies provide valuable insights into disease progression and outcomes.

Purpose of the Study:

  • To review and present findings from multiple sclerosis (MS) registry studies.
  • To assess the consistency of results across different MS registries.
  • To highlight the clinical and public health implications of MS registry data.

Main Methods:

  • A panel of experts conducted a review of established MS registry studies.
  • Analysis focused on overall results and consistency of findings across registries.
  • Data synthesis involved examining patterns of disability, progression predictors, and lifespan.

Main Results:

  • MS registry studies consistently report similar patterns in disability progression and predictors.
  • Progression rates after Expanded Disability Status Scale (EDSS) 4 are predictable and consistent across MS types.
  • Registry data indicate a shortened life expectancy for MS patients, underscoring its public health significance.

Conclusions:

  • MS registry findings should complement clinical trial data for optimized treatment.
  • Understanding MS-related mortality is essential for patient care and public health initiatives.
  • Integrating registry insights can improve long-term outcomes for individuals with multiple sclerosis.